Xu, M., Feng, R., Liu, Z., Zhou, X., Chen, Y., Cao, Y., Valeri, L., Li, Z., Liu, Z., Cao, S.-M., Liu, Q., Xie, S.-H., Chang, E. T., Jia, W.-H., Shen, J., Yao, Y., Cai, Y.-L., Zheng, Y., Zhang, Z., … Lin, X. (2024). Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediation. Cell Genomics, 4(2), 100474. https://doi.org/10.1016/j.xgen.2023.100474

Riley, C. A., & Gudis, D. A. (2023). Is There a Role for Adjuvant Therapy in Patients with Large Juvenile Nasopharyngeal Angiofibromas? The Laryngoscope, 133(11), 2831–2833. Portico. https://doi.org/10.1002/lary.30797

Schultz, K. A. P., Chintagumpala, M., Piao, J., Chen, K. S., Gartrell, R., Christison‐Lagay, E., Berry, J. L., Shah, R., & Laetsch, T. W. (2023). Children’s Oncology Group’s 2023 blueprint for research: Rare tumors. Pediatric Blood & Cancer, 70(S6). Portico. https://doi.org/10.1002/pbc.30574